|
Story |
Mental Health: Under ACA, Is It Better To Carve In or to Carve Out? |
Michael D. Dalzell |
|
Story |
Large employers agree on rewarding healthy behavior |
webadmin |
|
Story |
Monoclonal Antibody Now Available to Prevent Red Blood Cell Breakdown |
Thomas Morrow, MD |
|
Story |
Kaiser Official Defends Decision To Launch HSAs |
webadmin |
|
Story |
HIPAA Modifications Ease Burdens, But Don't Take Anything for Granted |
Steven J. Fox |
|
Story |
Smart Approach to Testing Needed For Fragile X Syndrome |
Michael Graf, MS |
|
Story |
Health Care Utilization & Costs For Cystic Fibrosis Patients with Pulmonary Infections |
Amy K. O'Sullivan, PhD |
|
Story |
Why Blogs? |
Alan Adler, MD |
|
Story |
Antidepressants Work Best For the Severely Depressed |
Martin Sipkoff |
|
Story |
Patient and Physician Satisfaction With a Pharmacist-Managed Anticoagulation Clinic: Implications for Managed Care Organizations |
Algha D. Lodwick, R. Ph. |
|
Story |
Are Gatekeepers Failing To Control Specialty Costs? |
webadmin |
|
Blog entry |
Super-Utilizers versus Non-Utilizers |
Steven Peskin MD |
|
Story |
‘B’ Isn’t Always for Biologics |
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD |
|
Story |
Marginal increase in chief medical officer pay |
webadmin |
|
Story |
When Success Sours: PBMs Under Scrutiny |
John Carroll |
|
Story |
Value-Based Insurance Design: Spend a Little More On Selected Patients For Payoff Down the Line |
Martin Sipkoff |
|
Story |
Cost Comparison of Immediate One-Stage And Tissue-Expander Breast Reconstructions After Mastectomy in Commercially Insured Patients |
Navin K. Singh, MD |
|
Story |
Tough Negotiations in Store Between Plans and Hospitals |
Ed Silverman |
|
Story |
A Multidimensional Framework For Specialty Drug Management |
Gregory K. Bell, PhD |
|
Blog entry |
Plans Confident They Can Handle Exchanges |
Frank Diamond |
|
Story |
Higher Copayments and Deductibles Delay Medical Care, A Common Problem for Americans |
Martin Sipkoff |
|
Story |
California Physicians Struggling — Problems Ahead for Other States? |
Michael D. Dalzell |
|
Story |
Molecular Diagnostic Testing Presents $5 Billion Conundrum |
Emad Rizk, MD |
|
Story |
Medicare Advantage Loses Its Advantage |
webadmin |
|
Story |
Comparing the Use of Intravenous Antibiotics Under the Medical Benefit With the Use of Oral Antibiotics Under the Pharmacy Benefit in Treating Skin and Soft Tissue Infections |
John Barron, PharmD |
